<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T09:47:49Z</responseDate>
  <request identifier="oai:figshare.com:article/33956254" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33956254</identifier>
        <datestamp>2026-09-21T17:30:51Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_272</setSpec>
        <setSpec>category_39</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_128</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>category_134</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Overview of the sampling design used for river water–sediment samples originating from the Ume River (Ume) and Selånger river (Sel). Treatments included irradiated and dark control with or without added influenza antivirals (IAs). Numbers indicate the replicate samples collected at each sampling time point. * Denote pre-treatment sampling (t = 0) where three samples from each river was analyzed.&lt;/p&gt;</dc:title>
          <dc:creator>Hanna Söderström Lindström (25084549)</dc:creator>
          <dc:creator>Sara H. Norström (25084552)</dc:creator>
          <dc:creator>Chaojun Tang (2294641)</dc:creator>
          <dc:creator>Richard H. Lindberg (272976)</dc:creator>
          <dc:creator>Josef D. Järhult (8275536)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Environmental Sciences not elsewhere classified</dc:subject>
          <dc:subject>Ecology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Hematology</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>Virology</dc:subject>
          <dc:subject>mallard model examining</dc:subject>
          <dc:subject>assessment combined data</dc:subject>
          <dc:subject>justify ia use</dc:subject>
          <dc:subject>risk patient groups</dc:subject>
          <dc:subject>ias requires balancing</dc:subject>
          <dc:subject>aquatic environments inhabited</dc:subject>
          <dc:subject>environmental stability ranged</dc:subject>
          <dc:subject>lowest environmental risk</dc:subject>
          <dc:subject>environmental risk ranking</dc:subject>
          <dc:subject>environmental risk posed</dc:subject>
          <dc:subject>oc ), zanamivir</dc:subject>
          <dc:subject>za ), peramivir</dc:subject>
          <dc:subject>aquatic environments</dc:subject>
          <dc:subject>environmental stability</dc:subject>
          <dc:subject>prudent use</dc:subject>
          <dc:subject>environmental release</dc:subject>
          <dc:subject>vivo experiments</dc:subject>
          <dc:subject>study aimed</dc:subject>
          <dc:subject>previously published</dc:subject>
          <dc:subject>oseltamivir carboxylate</dc:subject>
          <dc:subject>new experiments</dc:subject>
          <dc:subject>natural reservoir</dc:subject>
          <dc:subject>may contribute</dc:subject>
          <dc:subject>highest risks</dc:subject>
          <dc:subject>evaluated antivirals</dc:subject>
          <dc:subject>dabbling ducks</dc:subject>
          <dc:subject>clinical benefits</dc:subject>
          <dc:subject>clinical benefit</dc:subject>
          <dc:subject>carefully considered</dc:subject>
          <dc:subject>avian origin</dc:subject>
          <dc:subject>)&amp;# 8212</dc:subject>
          <dc:description>&lt;p&gt;Overview of the sampling design used for river water–sediment samples originating from the Ume River (Ume) and Selånger river (Sel). Treatments included irradiated and dark control with or without added influenza antivirals (IAs). Numbers indicate the replicate samples collected at each sampling time point. * Denote pre-treatment sampling (t = 0) where three samples from each river was analyzed.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-21T17:30:47Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0358447.t001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Overview_of_the_sampling_design_used_for_river_water_sediment_samples_originating_from_the_Ume_River_Ume_and_Sel_nger_river_Sel_Treatments_included_irradiated_and_dark_control_with_or_without_added_influenza_antivirals_IAs_Numbers_indica/33956254</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
